Status:

COMPLETED

Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden

Lead Sponsor:

GlaxoSmithKline

Conditions:

Solid Tumours

Eligibility:

All Genders

18+ years

Brief Summary

Introduction: Many reimbursement authorities use economic evaluation to help guide decisions regarding the adoption of new treatments in reimbursement systems. Survival and quality of life are often t...

Eligibility Criteria

Inclusion

  • Age \> 18

Exclusion

  • N/A

Key Trial Info

Start Date :

August 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2009

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01209091

Start Date

August 1 2009

End Date

October 1 2009

Last Update

February 3 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden | DecenTrialz